Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Multiple Myeloma 145Lymphoma, Follicular 41Lymphoma, Large B-Cell, Diffuse 36Lymphoma, B-Cell, Marginal Zone 24Recurrence 17Lymphoma, Mantle-Cell 17Lymphoma 16Neoplasms, Plasma Cell 15Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 11Neoplasms 9Lymphoma, B-Cell 8Smoldering Multiple Myeloma 7Burkitt Lymphoma 5Neoplasm, Residual 4Leukemia, Plasma Cell 4Waldenstrom Macroglobulinemia 3Myelodysplastic Syndromes 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Plasmacytoma 2Pancreatic Neoplasms 2Neuroblastoma 2Lymphoma, T-Cell 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia 2Hodgkin Disease 2Hematologic Diseases 2Urinary Bladder Neoplasms 1

Interventions

Specimen Handling 8pembrolizumab 7enfortumab vedotin 7Magnetic Resonance Spectroscopy 6avelumab 4Nivolumab 4Gemcitabine 3cabozantinib 2Ipilimumab 2Immunoglobulin G 2Disulfides 2Cisplatin 2Carboplatin 2CTLA-4 Antigen 2Biopsy 2vinflunine 1tremelimumab 1tocilizumab 1tamibarotene 1relatlimab 1eribulin 1erdafitinib 1durvalumab 1copanlisib 1atezolizumab 1Watchful Waiting 1Standard of Care 1Propranolol 1Practice Guidelines as Topic 1Plasmapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ureteral Neoplasms × Lenalidomide × 1 year × Clear all
NCT01352962 2026-04-14

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
18 enrolled
GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡